PRESS RELEASE published on 05/25/2023 at 07:30, 3 years 4 months ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
PRESS RELEASE published on 05/24/2023 at 09:30, 3 years 4 months ago BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
PRESS RELEASE published on 03/08/2023 at 17:20, 3 years 6 months ago Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
PRESS RELEASE published on 02/27/2023 at 16:00, 3 years 7 months ago Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
PRESS RELEASE published on 02/27/2023 at 07:30, 3 years 7 months ago BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
PRESS RELEASE published on 02/22/2023 at 14:00, 3 years 7 months ago BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
PRESS RELEASE published on 02/10/2023 at 11:04, 3 years 7 months ago EQS-Adhoc: BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Frères
PRESS RELEASE published on 01/16/2023 at 07:30, 3 years 8 months ago BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
PRESS RELEASE published on 01/10/2023 at 12:15, 3 years 8 months ago BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
PRESS RELEASE published on 01/10/2023 at 12:10, 3 years 8 months ago EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
Published on 10/07/2026 at 01:45, 4 hours 33 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 4 hours 48 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 5 hours 13 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 6 hours 33 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 6 hours 46 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/06/2026 at 19:05, 11 hours 12 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 11 hours 47 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 12 hours 13 minutes ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 12 hours 17 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 18:00, 12 hours 17 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026
Published on 10/06/2026 at 19:15, 11 hours 3 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 11 hours 3 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 11 hours 38 minutes ago Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 11 hours 38 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 12 hours 3 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
